Further researches have shown that KIF4A operates as an oncogene and plays critical roles in a number of malignancies, including breast cancer, prostate cancer and colorectal cancer (Matsumoto et al., 2018; Xue et al., 2018; Cao et al., 2020). Here, KIF4A is linked to breast cancer.